Innovative mRNA technology promises rapid vaccine development for emerging diseases.
A Singapore-based biotechnology company has unveiled an innovative mRNA platform that could revolutionize vaccine development.
Breakthrough Technology
The new platform can develop vaccine candidates in just 6 weeks, compared to traditional methods that take months.
Clinical trials are expected to begin in early 2025.
Leave a Comment
Your email address will not be published. Required fields are marked with *